Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00917683 · ClinicalTrials.gov registry record
Investigation of Neuroserpin as an Autism Candidate Gene
A clinical trial, sponsored by State University of New York - Upstate Medical University.
- Terminated
- Registry status
- 5
- Enrollment target
NCT00917683: Clinical Trial study, sponsored by State University of New York - Upstate Medical University.
NCT00917683 is a clinical trial that was terminated before completion, run by State University of New York - Upstate Medical University. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00917683 was terminated before completion, sponsored by State University of New York - Upstate Medical University.
- TERMINATED
- Registry status
- 5 participants
- Enrollment target
Study Summary
Previously it has been shown that Familial Encephalopathy with neuroserpin inclusion bodies (FENIB) patients develop abnormalities that partially overlap with Autism Spectrum disorders (ASD), confounded with additional features that could be explained by inclusion body formation not expected in subjects with inclusion body forming SERPINI1 mutations. There is no described human neuroserpin deficiency phenotype. The neuroserpin knockout mouse phenotype also suggests a possible overlap with autism. Neuroserpin could contribute directly at the synapse or through altered neuron migration during early development leading to the "underconnectivity" that underlies autism by potentially contributing to the excess of short connections and not enough long ones seen in autistic brains, possibly due to an imbalance in pruning of neurons and synapses early in life. It is thus proposed to sequence the neuroserpin gene in initially 20, and subsequently up to 100 idiopathic autistic patients selected as having the language impairment and perseveration endophenotypes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2009-06 |
| Est. Completion | 2012-04 |
Why NCT00917683 stopped before completion
NCT00917683 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00917683 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00917683 about?
NCT00917683 is a clinical study titled "Investigation of Neuroserpin as an Autism Candidate Gene". Previously it has been shown that Familial Encephalopathy with neuroserpin inclusion bodies (FENIB) patients develop abnormalities that partially overlap with Autism Spectrum disorders (ASD), confounded with additional features that could be explained by inclusion body formation not expected in subj...
What is the current status of trial NCT00917683?
This trial is currently terminated. The enrollment target is 5 participants. The study started on 2009-06. Estimated completion is 2012-04.
Who is sponsoring clinical trial NCT00917683?
This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia